The pharmaceutical industry is facing unprecedented levels of uncertainty. Regulatory changes, pricing pressures, evolving healthcare policies, supply chain disruptions, and shifting market demand have made traditional annual budgeting and static forecasting increasingly ineffective.

For finance leaders, FP&A teams, and business executives, the challenge is no longer simply producing forecasts, but making faster, more informed decisions in a rapidly changing environment.

Leading pharmaceutical companies are therefore adopting Dynamic Rolling Forecasting powered by Enterprise Performance Management (EPM) platforms to improve forecast accuracy, increase organizational agility, and drive better business outcomes.

EVOX EPM enables pharmaceutical organizations to replace spreadsheet-driven planning with AI-powered forecasting, integrated financial planning, and real-time performance insights.

Pharmaceutical companies operate in one of the most complex planning environments across all industries.

Regulatory and Market Volatility

Changes in reimbursement policies, government regulations, drug pricing controls, and market access requirements can significantly impact revenue forecasts and profitability projections.

Fragmented Enterprise Data

Critical planning information is often scattered across ERP systems, CRM platforms, manufacturing systems, supply chain applications, and spreadsheets. Manual consolidation creates delays and increases the risk of errors.

Slow Forecasting Cycles

Many pharmaceutical companies still spend weeks collecting, validating, and consolidating data before forecasts can be finalized, leaving decision-makers with outdated information.

Limited Visibility into Future Risks

Traditional forecasting models rely heavily on historical data and fixed assumptions, making it difficult to anticipate changing market conditions and emerging risks.

Complex Multi-Dimensional Planning Requirements

Finance teams must manage planning across products, brands, therapeutic areas, business units, geographies, distributors, and channels simultaneously.

The result is slower decision-making, reduced forecast accuracy, and missed opportunities for growth.

Dynamic Rolling Forecasting is a continuous planning methodology that updates forecasts regularly using the latest operational, commercial, and financial data.

Unlike traditional annual budgets that quickly become outdated, rolling forecasts provide a constantly refreshed view of future performance, enabling organizations to respond proactively to change.

With EVOX EPM, forecasting becomes a strategic business process rather than a periodic financial exercise.

1. Continuous Planning Instead of Annual Planning

Rolling forecasts continuously update assumptions and business drivers, ensuring forecasts remain relevant throughout the year.

This allows pharmaceutical companies to respond quickly to regulatory changes, market shifts, and evolving demand patterns.

2. AI Powered Forecast Accuracy

EVOX AI analyzes historical trends, business drivers, and operational data to generate predictive insights and improve forecasting accuracy.

Finance teams gain greater confidence in future projections while reducing reliance on manual assumptions.

3. Integrated Enterprise Planning

EVOX connects finance, commercial operations, supply chain, manufacturing, and management teams through a unified planning platform.

All stakeholders work from a single source of truth, improving collaboration and alignment across the organization.

4. Automated Data Integration and Reconciliation

Native integration capabilities and built-in ETL functionality automatically collect and transform data from ERP, CRM, and operational systems.

This significantly reduces manual effort and eliminates spreadsheet-driven planning challenges.

5. Advanced Scenario Planning and What-If Analysis

Pharmaceutical companies can instantly evaluate the impact of:

• Drug pricing changes
• Regulatory policy adjustments
• Product launches
• Market expansion initiatives
• Supply chain disruptions
• Currency fluctuations

Management teams can compare multiple scenarios and make faster, data-driven decisions.

Daiichi Sankyo, a leading global pharmaceutical company, faced challenges including fragmented data sources, lengthy forecasting cycles, and extensive manual reconciliation.

By implementing EVOX Dynamic Rolling Forecasting, the company achieved:

• More than 40% reduction in forecasting cycle time
• Improved forecast accuracy through predictive analytics
• Enhanced visibility into demand drivers and business performance
• Better alignment between finance, commercial, and operational teams
• Faster strategic decision-making across the organization

The result was a more agile and data-driven planning process that supported sustainable business growth.

Unlike traditional planning tools that focus solely on budgeting, EVOX provides a complete AI-powered Enterprise Performance Management platform that integrates:

• Budgeting and Planning
• Dynamic Rolling Forecasting
• Financial Consolidation
• Management Reporting
• AI Analytics
• Scenario Planning
• Workflow Management
• Enterprise Data Integration

Key EVOX Advantages

• AI-Powered Forecasting and Predictive Analytics
• Driver Based Planning and Scenario Modeling
• Integrated Planning, Consolidation, and Reporting
• Built in ETL and Enterprise Data Connectivity
• Excel Friendly User Experience
• Rapid Deployment and Fast Time to Value
• High Performance Processing for Large Data Volumes
• Flexible Deployment: Onpremises, Private Cloud, or Public Cloud

In today’s pharmaceutical industry, the ability to anticipate change is becoming a critical competitive differentiator.

Organizations that adopt Dynamic Rolling Forecasting can improve forecast accuracy, accelerate decision-making, optimize resource allocation, and respond more effectively to market uncertainty.

With EVOX EPM, pharmaceutical companies can move beyond traditional budgeting and transform forecasting into a strategic capability powered by AI, automation, and real-time business intelligence.

Ready to Modernize Pharmaceutical Planning?

Discover how EVOX EPM helps pharmaceutical organizations improve forecasting accuracy, strengthen financial control, and accelerate strategic decision-making through AI-powered Enterprise Performance Management.

Tony Lai is the General Manager of EVOX Platform, where he works with finance leaders across industries to improve strategic planning, forecasting, and enterprise performance management. He frequently collaborates with CFOs and FP&A teams in life sciences organizations to strengthen financial visibility across complex R&D portfolios.